These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22489721)

  • 21. Circulating microRNAs in Cardiovascular Diseases.
    Orlicka-Płocka M; Gurda D; Fedoruk-Wyszomirska A; Smolarek I; Wyszko E
    Acta Biochim Pol; 2016; 63(4):725-729. PubMed ID: 27755614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in development and disease.
    Erson AE; Petty EM
    Clin Genet; 2008 Oct; 74(4):296-306. PubMed ID: 18713256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of miRNAs in coronary artery disease.
    Papageorgiou N; Tousoulis D; Charakida M; Briasoulis A; Androulakis E; Tentolouris C; Siasos G; Stefanadis C
    Curr Top Med Chem; 2013; 13(13):1540-7. PubMed ID: 23745806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.
    Halushka PV; Goodwin AJ; Halushka MK
    Annu Rev Pathol; 2019 Jan; 14():211-238. PubMed ID: 30332561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs and the heart: small things do matter.
    Papoutsidakis N; Deftereos S; Kaoukis A; Bouras G; Giannopoulos G; Theodorakis A; Angelidis C; Hatzis G; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):216-30. PubMed ID: 23470079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of miR-214 in cardiovascular diseases.
    Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
    Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA in cardiovascular biology and disease.
    Wojciechowska A; Braniewska A; Kozar-Kamińska K
    Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs in the onset and development of cardiovascular disease.
    Vickers KC; Rye KA; Tabet F
    Clin Sci (Lond); 2014 Feb; 126(3):183-94. PubMed ID: 24102098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA: A new therapeutic strategy for cardiovascular diseases.
    Samanta S; Balasubramanian S; Rajasingh S; Patel U; Dhanasekaran A; Dawn B; Rajasingh J
    Trends Cardiovasc Med; 2016 Jul; 26(5):407-19. PubMed ID: 27013138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MicroRNAs: what cardiologists should know about them?].
    Mericskay M
    Presse Med; 2015; 44(7-8):761-71. PubMed ID: 26163829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
    Condorelli G; Latronico MV; Cavarretta E
    J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs in Cardiovascular Disease: Perspectives and Reality.
    Papageorgiou N; Tslamandris S; Giolis A; Tousoulis D
    Cardiol Rev; 2016; 24(3):110-8. PubMed ID: 26135901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet miRNAs and cardiovascular diseases.
    Fuentes E; Palomo I; Alarcón M
    Life Sci; 2015 Jul; 133():29-44. PubMed ID: 26003375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microRNAs: novel biomarkers for cardiovascular diseases.
    Xu J; Zhao J; Evan G; Xiao C; Cheng Y; Xiao J
    J Mol Med (Berl); 2012 Aug; 90(8):865-75. PubMed ID: 22159451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update.
    Islas JF; Moreno-Cuevas JE
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.
    Wang J; Liew OW; Richards AM; Chen YT
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.